Enanta’s chemistry-driven approach and drug discovery capabilities are focused on small molecule drugs for the treatment of viral infections and liver diseases such as respiratory syncytial virus (RSV), hepatitis B virus (HBV), non-alcoholic steatohepatitis (NASH), human metapneumovirus (hMPV) and SARS-CoV-2. Learn more about our research.

Latest News